Chasing_Tendies

APLS ; target $40 pushed by 17% short interest

做多
NASDAQ:APLS   Apellis Pharmaceuticals, Inc.
Short interest of 17% can push this out of the wedge formed. Pharma stocks will make a comeback closer we get to vaccine hypes again once the tech bubble pops

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。